Out-licensing: Pharmaceutical/Nutrition & Dermatological

Latest: Watch here for details of new products and services.

About Us: Pharmalicensing - Open Innovation for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Partneringtools; Reports; Partnering Consulting; Due Diligence; Comparison
Due Diligence: Overview; Top Applications; Online Panel Discussions; Request Consultation
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs; Forums
Contact Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing Ltd
is a division of

Up-to-date access to technology licensing opportunities worldwide.

Displaying 1..4 of 4 - per page
Order by

Antroquinonol® is a non-toxic, highly effective cancer treatment agent, developed using natural organic chemistry. More

Vitamin C offered in 300mg doses More

Vitamin C offered in 500mg doses alone More

Enzymatic production of a broad range of biosurfactants including generation of molecules that cannot be prepared using chemical synthesis. More

Displaying 1..4 of 4 - per page
Order by

Therapeutic target: Acne; Actinic keratosis; Alopecia; Bacterial infection; Burns; Chronic idiopathic urticaria; Cosmetic procedures; Dermal ulcers; Dermatitis, allergic; Dermatitis, atopic; Dermatological (other); Dermatosis; Eczema; Fungal infection; Hirsutism; Human B19 parvovirus; Hyperkeratosis; Ichthyosis; Impetigo; Insect bite; Keloids; Lupus; Male pattern baldness; Paget's disease; Photodamage; Pruritis; Psoriasis; Scleroderma; Shingles; Skin infection (other); Ulcer, diabetic; Urticaria; Wound healing
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Industry news: Pharmalicensing provides comprehensive industry coverage.